Fluid overload is the single biggest driver of high blood pressure in people on dialysis, but it is far from the only one. Roughly 85 percent of patients with end-stage kidney disease have hypertension, a rate that dwarfs what you see in the general population. The reasons stack up: hormonal systems that refuse to quiet down, arteries that stiffen and calcify, nerves that fire too aggressively, and even the dialysis prescription itself can push blood pressure higher. Understanding these overlapping causes matters because treating just one and ignoring the rest rarely brings blood pressure under control.
Fluid Overload Is the Dominant Cause
When healthy kidneys stop working, they stop removing excess water and sodium. Between dialysis sessions, fluid accumulates. That extra volume raises cardiac output and pushes up pressure against blood vessel walls. The effect is worst at the end of the long gap between sessions: if you dialyze on a Monday-Wednesday-Friday schedule, blood pressure tends to be highest on Monday morning, after two days without treatment. Higher interdialytic weight gain tracks closely with higher pre-dialysis blood pressure, and ambulatory blood pressure climbs during that extended interval as well.1PubMed Central. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management
The volume story goes deeper than just extra water. Fluid expansion triggers the release of substances that inhibit sodium-potassium pumps in cell membranes. The downstream effect is a rise in calcium inside the smooth muscle cells that line blood vessels, and more intracellular calcium means tighter constriction. So the same excess fluid that mechanically stretches the heart also chemically tightens the arteries.2The Open Urology & Nephrology Journal. Hypertension in Hemodialysis. An Overview on Physiopathology and Therapeutic Approach in Adults and Children
One of the practical headaches here is “dry weight,” the target weight a patient should reach by the end of each dialysis session once all extra fluid has been removed. If the care team overestimates dry weight even slightly, a patient walks out of every session carrying hidden fluid. Over weeks, that chronic fluid overload becomes the primary force behind persistent hypertension.3PubMed. Calf bioimpedance ratio improves dry weight assessment and blood pressure control in hemodialysis patients Reassessing dry weight regularly, sometimes with tools like bioimpedance measurements, can make a real difference in blood pressure control.
Hormonal Systems That Will Not Turn Off
In a healthy body, the renin-angiotensin-aldosterone system helps regulate blood pressure by adjusting how much sodium and water you retain. When blood volume drops, aldosterone goes up. When volume is restored, aldosterone comes back down. In people on hemodialysis, this feedback loop is broken. Studies show that dialysis patients exist in a state of high volume and inappropriately high aldosterone at the same time, a combination that should not happen if the regulatory system were working correctly.4PubMed Central. Disordered aldosterone-volume relationship in end-stage kidney disease The excess aldosterone promotes even more sodium retention, more fluid buildup, and direct damage to the heart and blood vessels, compounding the problem that volume overload already creates.
On top of the hormonal overdrive, the sympathetic nervous system fires at abnormally high rates. A landmark study measured nerve activity directly in dialysis patients and found that the rate of sympathetic nerve firing was about two and a half times higher than in people with normal kidneys. The source of that overactivity appears to be the failing kidneys themselves: patients who had undergone bilateral nephrectomy (removal of both kidneys) had sympathetic firing rates similar to healthy controls, along with lower vascular resistance and lower blood pressure.5PubMed. Sympathetic overactivity in patients with chronic renal failure In other words, the diseased kidneys send a constant alarm signal to the nervous system, which responds by clamping down blood vessels even when the body does not need it.
Arteries That Harden and Calcify
Dialysis patients develop arterial stiffness at rates far exceeding the general population, and it is one of the strongest independent predictors of cardiovascular death in this group.6PubMed. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management The process is driven largely by calcification of the arterial media, the muscular middle layer of the vessel wall. Healthy arteries expand when the heart pumps and then recoil, cushioning the force of each heartbeat. Calcified arteries lose that elasticity. The result is a wider gap between systolic and diastolic blood pressure (a high pulse pressure), which places extra strain on the heart and disrupts blood flow to the coronary arteries.
The calcification itself is tied to disturbed mineral metabolism. Elevated phosphorus, calcium, and parathyroid hormone levels all play a role, and these derangements are nearly universal in dialysis patients. A study of dialysis patients found that a vascular calcification score above a certain threshold was independently associated with both pulse wave velocity (a direct measure of arterial stiffness) and pulse pressure.7PubMed. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients The connection between bone and vascular health is one of the more complex pieces of the puzzle. As bone metabolism goes awry in kidney disease, calcium and phosphorus that should be staying in bone end up depositing in artery walls instead.8PubMed Central. Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease
Damaged Blood Vessel Linings
The endothelium, the thin inner lining of blood vessels, produces nitric oxide, a molecule that relaxes vessel walls and keeps blood pressure in check. In dialysis patients, that lining is under constant attack. One mechanism involves advanced glycation end products, waste compounds that accumulate when kidneys cannot clear them. These compounds latch onto receptors on endothelial cells and suppress the enzyme responsible for making nitric oxide. When researchers exposed human aortic endothelial cells to serum fractions from chronic kidney disease patients rich in these compounds, nitric oxide production dropped compared to cells exposed to healthy serum. Blocking the receptor reversed the effect.9PubMed Central. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation
Parathyroid hormone, which runs high in most dialysis patients because of mineral imbalances, also damages the vessel lining. Research has identified parathyroid hormone receptors directly on vascular smooth muscle, and elevated hormone levels appear to impair the endothelium’s ability to regulate blood vessel tone. The combined effect of high parathyroid hormone and elevated calcium-phosphorus product creates what researchers describe as a dual mechanism of vascular injury: one arm targeting the endothelium and the other promoting calcification in the arterial wall.10PubMed. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism
How the Dialysis Prescription Itself Affects Blood Pressure
The sodium concentration in the dialysate fluid matters more than many patients realize. When dialysate sodium is set higher than what the patient’s blood naturally carries, sodium moves into the bloodstream during treatment. That extra sodium drives thirst after the session, the patient drinks more, and the next interdialytic weight gain is larger. A study that raised dialysate sodium based on patients’ serum levels found that weight gain between sessions climbed and thirst scores worsened, with no meaningful benefit to blood pressure stability during treatment.11PubMed. Increasing the dialysate sodium concentration based on serum sodium concentrations exacerbates weight gain and thirst in hemodialysis patients
A prospective study tested three different dialysate sodium levels and measured ambulatory blood pressure over 72 hours after each. Average systolic blood pressure rose progressively as dialysate sodium increased, climbing by roughly 7-8 mmHg when going from the lowest to the highest concentration tested. The pattern held for diastolic blood pressure and persisted around the clock, including overnight.12Clinical Kidney Journal. The effect of different dialysate sodium concentrations on ambulatory blood pressure in hemodialysis patients: a prospective interventional study For patients struggling with hypertension between sessions, lowering dialysate sodium even modestly can be a straightforward intervention.
Erythropoiesis-stimulating agents, the medications used to treat anemia in dialysis patients, are another underappreciated contributor. These drugs boost red blood cell production, which is their purpose, but they also raise blood pressure through several pathways. They increase endothelin-1, a potent vessel constrictor, while simultaneously reducing nitric oxide, the molecule that relaxes vessels. On top of that, as more red blood cells enter circulation, blood becomes more viscous and harder to push through the vascular system. The blood pressure rise typically tracks with the increase in red blood cell mass.13PLoS ONE. Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
When Blood Pressure Rises During Dialysis
Most people expect blood pressure to drop during hemodialysis as fluid is removed. In some patients, the opposite happens: pressure climbs during or immediately after the session, a phenomenon called intradialytic hypertension. The causes are thought to include subclinical volume overload that is not being fully addressed, sympathetic nervous system activation triggered by the treatment, activation of the renin-angiotensin system, and endothelial dysfunction.14PubMed Central. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis Certain blood pressure medications that are removed by dialysis can also contribute, because their protective effect disappears partway through the session.
The choice of antihypertensive drug class has real implications for blood pressure stability on dialysis. A study found that patients on beta blockers or combined alpha-beta blockers had the highest rates of intradialytic blood pressure drops, while calcium channel blockers were associated with the lowest risk. ACE inhibitors and angiotensin receptor blockers fell in between.15Clinical Kidney Journal. Choosing the right antihypertensive drug to avoid intradialytic hypotension This does not mean calcium channel blockers are best for every patient, but it does mean the dialyzability of a medication, how easily it is pulled out of the blood during treatment, should factor into prescribing decisions.
More Frequent or Longer Dialysis Sessions
Standard hemodialysis runs three times per week, typically for about four hours. Switching to more frequent sessions or longer overnight sessions consistently lowers blood pressure. The Frequent Hemodialysis Network trials compared daily hemodialysis to the standard three-times-weekly schedule and found that daily sessions lowered pre-dialysis systolic blood pressure by about 7-8 mmHg. Nocturnal hemodialysis produced a similar drop. Both approaches sustained their blood pressure benefits through a year of follow-up and allowed patients to reduce the number of antihypertensive medications they were taking.16PubMed Central. Effects of Frequent Hemodialysis on Blood Pressure: Results from the Randomized Frequent Hemodialysis Network Trials
The mechanism behind these improvements is not just better fluid removal, although that plays a role. Nocturnal home hemodialysis has been shown to lower total peripheral resistance and reduce circulating norepinephrine, the chemical messenger of sympathetic activation. In one study, 24-hour mean arterial pressure dropped from about 102 to 90 mmHg after two months of nocturnal treatments, a clinically meaningful change.17PubMed. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis The gentler, more gradual fluid removal of longer sessions appears to calm the sympathetic overdrive that conventional short sessions can provoke.
Hemodialysis Versus Peritoneal Dialysis
Peritoneal dialysis removes fluid continuously or in multiple daily exchanges rather than in three sharp weekly bursts. In theory, this should produce steadier blood pressure. The picture in practice is more nuanced. One comparison of the same patients during periods on hemodialysis and on peritoneal dialysis found that more patients needed blood pressure medication during peritoneal dialysis, and fewer achieved adequate pressure control. The authors attributed this partly to weight gain during peritoneal dialysis, reflecting gradual fluid accumulation.18PubMed. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients
Other research emphasizes the flip side: the cyclic volume depletion and repletion of hemodialysis can trigger sympathetic activation and endothelial stress that peritoneal dialysis avoids. The more gradual fluid removal in peritoneal dialysis is generally associated with less blood pressure variability, which itself is a risk factor for cardiovascular events. The tradeoff is that peritoneal dialysis patients sometimes drift into chronic mild fluid overload without the dramatic pre-dialysis weight spike that forces the issue on hemodialysis.19Current Hypertension Reviews. Blood Pressure Management in Dialysis: A Comparative Review of Hemodialysis and Peritoneal Dialysis Neither modality is inherently better for blood pressure; each has failure modes that require different vigilance.
Sleep Apnea and the Overnight Blood Pressure Problem
Obstructive sleep apnea is far more common in dialysis patients than in the general population, and it creates a vicious loop with hypertension. Fluid that accumulates during the day redistributes to the upper body when the patient lies down at night, contributing to airway narrowing and apnea episodes. Each apnea episode triggers a surge of sympathetic activity and a spike in blood pressure. Over time, this pattern prevents the normal overnight dip in blood pressure that healthy people experience, leading to sustained hypertension that is resistant to standard medications.20PubMed Central. The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology If blood pressure remains stubbornly high despite good fluid management and appropriate medications, undiagnosed sleep apnea is worth investigating.
The Vascular Access Factor
The arteriovenous fistula used for hemodialysis access is essentially a short circuit between an artery and a vein. It diverts a substantial volume of blood directly from the arterial to the venous system, bypassing the resistance of the capillary bed. This changes cardiac workload in measurable ways. A meta-analysis found that after an arteriovenous fistula is created, systolic blood pressure drops by about 9 mmHg and diastolic by about 6 mmHg, while cardiac output increases.21PubMed Central. Effects of Arteriovenous Fistula on Blood Pressure in Patients With End-Stage Renal Disease: A Systematic Meta-Analysis When fistulas are ligated (tied off), blood pressure tends to rise again.
The blood pressure drop from a fistula might sound beneficial, but the increased cardiac output is not free. The heart has to pump harder to maintain pressure in the rest of the body while a portion of blood takes the low-resistance fistula route. Over time, this can lead to increases in left ventricular volume and contribute to cardiac enlargement.22PubMed Central. Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function For patients who already have heart failure or very high-flow fistulas, this additional cardiac burden can paradoxically worsen cardiovascular outcomes even if the blood pressure number looks better.
The Reverse Epidemiology Paradox
In the general population, higher blood pressure means higher cardiovascular risk. In dialysis patients, the relationship is more complicated. Several large analyses have found that low blood pressure in dialysis patients is associated with higher mortality, not lower. One study reported that the lowest mortality was seen in patients with pre-dialysis systolic pressures between 160 and 189 mmHg, values that would be alarming in someone without kidney disease. Normal-to-low pre-dialysis pressures were linked to significantly increased risk of death.23PubMed. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions
This does not mean high blood pressure is actually protective. The most likely explanation is confounding by illness: patients with low blood pressure in dialysis often have failing hearts, severe malnutrition, or advanced illness that drives pressure down. In a study of peritoneal dialysis patients, systolic blood pressure trended down to an average of about 117 mmHg before death in non-survivors, compared to 141 mmHg in survivors, and this decline tracked with worsening heart function.24PubMed Central. Reverse Epidemiology of Blood Pressure in Peritoneal Dialysis Associated with Dynamic Deterioration of Left Ventricular Function The paradox complicates blood pressure targets for dialysis patients and is one reason clinicians remain cautious about aggressively lowering blood pressure in this population without understanding why it is elevated in a given patient.
Uremic Toxins and the Gut Connection
Dialysis removes many but not all waste products that accumulate in kidney failure. Protein-bound uremic toxins, substances produced partly by gut bacteria, are poorly cleared by standard hemodialysis. Some of these toxins have direct effects on the heart and blood vessels, promoting inflammation, oxidative stress, and endothelial damage.25PubMed Central. Gut Microbiota and Cardiovascular Uremic Toxicities The gut microbiome itself shifts in chronic kidney disease, with bacterial populations that produce more of these harmful compounds. This area of research is still developing, but it adds another layer to why blood pressure control on dialysis is so much harder than simply pulling off extra fluid and prescribing the right pill. The chronic, low-grade vascular injury from retained toxins likely contributes to the arterial stiffness and endothelial dysfunction that maintain hypertension even when fluid status is well managed.